Filter

101 - 110 of 227 Results

  • Round 3: Legal Challenges to Contraceptive Coverage at SCOTUS

    Issue Brief

    This brief explains how the new regulations issued by the Trump Administration would change the contraceptive coverage requirement for employers and affect women’s coverage, the legal positions for challenging and defending these regulations, the potential rulings, and the broader ramifications.

  • Donor Government Funding for Family Planning in 2019

    Report

    Donor government support for global family planning efforts totaled US$1.50 billion in 2018, up 19% from 2017 (US$1.26 billion) – and the highest level since tracking efforts began following the London Summit on Family Planning in 2012.

  • Donor Government Funding for International Family Planning Declines After Increasing the Previous Three Years

    News Release

    A new KFF analysis finds donor government support for global family planning efforts totaled US$1.40 billion in 2020, a decline of US$114 million compared to last year’s level of US$1.52 billion. This decline in donor funding was largely due to the decreased funding from the UK, family planning’s second largest donor after the US. The UK decline was partly due to the timing of disbursements, but also to the effect of the COVID-19 pandemic on…

  • Two Women’s Health Policy Issues to Monitor in 2021

    News Release

    With President-elect Joe Biden and a new Congress taking office next month, newly updated KFF briefs examine two women’s health policy issues awaiting federal policymakers in 2021. President-elect Biden campaigned on reversing the Trump Administration’s regulations for the Title X family planning program, which require complete financial and physical separation from abortion services, including referrals, for family planning providers funded by the program. The Current Status of the Title X Network and the Path Forward…

  • UNFPA Funding and Kemp-Kasten: An Explainer

    Issue Brief

    This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population…

  • Contraceptive Implants

    Fact Sheet

    The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.

  • Briefing on Access to Reproductive Health Care for Low-Income Women in Five Communities

    Event Date:
    Event

    As policy debates over the future of access to reproductive and sexual health services heat up at the national and state levels, understanding how these policies are playing out on the ground requires getting beyond the statistics. Earlier this year, KFF, working with Health Management Associates, conducted case studies and focus groups in five different communities to hear directly from providers and low-income women.  The study addressed how national, state, and local policies, as well…

  • Donor Government Support for Family Planning Peaks in 2018

    News Release

    A new KFF analysis finds donor government support for global family planning efforts totaled US$1.50 billion in 2018, up 19 percent from 2017 (US$1.26 billion) – and the highest level since tracking efforts began following the London Summit on Family Planning in 2012. Since 2012, total donor government funding for family planning has risen by more than US$400 million. Funding for family planning supports a range of activities including contraceptives, information, education and communication activities; and capacity…

  • Litigation Challenging Title X Regulations

    Issue Brief

    This brief provides an overview of the legal challenges to the Trump Administration final Title X regulations and summarizes the key positions of the plaintiffs and HHS.